A new molecular imaging agent can accurately identify a crucial biomarker found among many different types of cancer.
Study characterizes SARS-CoV-2 subvariants to inform development of next-generation COVID-19 vaccines
Researchers characterized two novel SARS-CoV-2 XBB variants, EG.5.1 and XBB.2.3.